nhs tirzepatide Mounjaro: New diabetes jab that sparked diabetes row in US could get approved on NHS to restrict new weight-loss

Created by the guys of Team Truly with mens coarse facial hair, lower skin pH, and scientifically thicker, oilier skin in mind every step of the way

Medically reviewed by Alan Lucks | MD , Alan Lucks MDPC Private Practice - New York on February 14th, 2026

Mounjaro works by mimicking natural incretin hormones that regulate blood sugar levels, enhance insulin secretion when glucose is elevated, suppress glucagon release, slow gastric emptying, and reduce appetite

Tirzepatide was associated with a dose-dependent reduction in the progression of nephropathy, as measured by a composite endpoint of new-onset macroalbuminuria, a sustained decline in estimated glomerular filtration rate (eGFR) of 40% or more, progression to end-stage renal disease, or renal death, when compared to insulin glargine

Manufacturing Complexity Semaglutide is a GLP-1 receptor agonist that requires sophisticated biotechnology manufacturing processes